joseph capper: Live & Latest News Updates : Vimarsana.com

MiMedx Says FDA Still Won't Budge on Axiofill Designation, Files Lawsuit

By Dean Seal MiMedx Group said federal regulators are sticking to their position that its Axiofill product doesn't meet regulatory requirements for a certain classification sought by the...

Company Warned Over Human Placenta Product

FDA tells MiMedx that its wound-healing product must be regulated as a biologic

FDA rips MiMedx with warning letter for its placental collagen wound-care treatment

MiMedx Targets Profitability with Strategic Realignment, Suspends Knee Osteoarthritis Program Activities - MiMedx Group (NASDAQ:MDXG)

MiMedx Group Inc (NASDAQ: MDXG) announced a strategic realignment to focus its resources on its Wound & Surgical business, driving profitability and 

MiMedx Group (MDXG) Announces Strategic Realignment

MiMedx Group Plans Strategic Realignment to Focus on Wound and Surgical Business

By Stephen Nakrosis MiMedx Group said on Tuesday it will focus on accelerating growth of its wound and surgical business in a move it expects will improve...

MIMEDX Announces First Quarter 2023 Operating and Financial Results

First Quarter Net Sales of $71.7 Million Reflect an Increase of 21.7% Over the Prior Year Period Revenue Growth & Cost Controls Help Drive Improvements in Net Loss, EBITDA & Adjusted EBITDA1 ... | May 2, 2023

MiMedx appoints Joseph Capper as CEO

MiMedx (Nasdaq:MDXG) today announced it appointed Joseph Capper as CEO and director, effective immediately.

Spooky 1790s scrapbook featuring sketches of 'The Yorkshire Witch', 'The Irish Giant', and 'The Remarkable Shrew' is unearthed

Philips in €2.3bn biotelemetry merger

December 18, 2020 // By Nick Flaherty Philips says it is to merge with leading US-based home heart monitoring firm BioTelemetry in a €2.3bn cash deal. The all-cash deal with BioTelemetry (Malvern, PA) will boost Philips’ home monitoring Connected Care division and brings a US clinical trials division. The deal also brings a US cloud patient monitoring system at a time when the handling of patient data will be a key issue between the US and Europe. BioTelemetry has 1900 staff and sales of $439m in 2019 with several acquisitions of European medical systems companies in the last two years, including Lifewatch AG in Switzerland and ADEA Medical AB in Sweden.